Intraocular lens implantation device
Latest Santen Pharmaceutical Co., Ltd. Patents:
The dot-dot broken lines are directed to illustrative environmental subject matter that forms no part of the claimed design or to portions of the devices that form no part of the claimed design. The dash-dot broken lines represent bounds of the claimed design and do not themselves form a part of the claimed design.
Claims
The ornamental design for an intraocular lens implantation device, as shown and described.
6312433 | November 6, 2001 | Butts et al. |
6371960 | April 16, 2002 | Heyman et al. |
D674086 | January 8, 2013 | Khalaj |
8435289 | May 7, 2013 | Cole et al. |
D690417 | September 24, 2013 | Solomon |
20070050023 | March 1, 2007 | Bessiere et al. |
20070150054 | June 28, 2007 | Pynson |
20120022547 | January 26, 2012 | Hildebrand et al. |
20120221102 | August 30, 2012 | Tanaka et al. |
20140135784 | May 15, 2014 | Maroscheck et al. |
Type: Grant
Filed: Apr 29, 2013
Date of Patent: Aug 25, 2015
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka-shi, Osaka)
Inventors: Christian Winfried Wargner (Osaka), Yoshitaka Yamada (Osaka), Katsuyuki Ueno (Osaka)
Primary Examiner: Garth Rademaker
Assistant Examiner: Samantha Q Lawrence
Application Number: 29/442,737